Creatine Kinase MB (CKMB) Isoenzymes Available from Lee Biosolutions

ST. LOUIS – Lee Biosolutions is now offering human and recombinant creatine kinase MB (CKMB) isoenzymes to the clinical research community at LeeBio.com.

Creatine kinase MB is a cardiac marker. It is an enzyme produced primarily in the heart. Elevated levels in the bloodstream are indicative of heart damage, probably due to a heart attack. It has also been found effective in determining whether or not clot-dissolving drugs are working. CKMB levels are one of a number of blood tests typically administered to patients presenting with chest pain.

“CKMB is one of a number of substances found in the blood that are helping researchers predict, diagnose and treat heart attacks better than ever before,” Lee Biosolutions President Burton Lee said. “Researchers use these materials to advance their understanding of the critical role they play in heart-related illness.”

Lee Biosolutions offers creatine kinase MB derived from the human heart, as well as lab created recombinant CKMB. In addition, the company has a variety of creatine kinase based products for other research purposes as well.

Additional products in Lee Biosolutions’ cardiac market line include myoglobin, C-reactive protein, Myeloperoxidase, Troponins, other CK isoenzymes and lipoproteins. Some markers are more conclusive than others, but all are indicative at some level of a heart attack.

Within 3-6 hours following a heart attack, creatine kinase MB levels will begin to rise. The levels will typically peak within 24 hours. As a result, CKMB is very reliable indicator of recent heart attack, but is essentially ineffective at diagnosing a heart attack that has occurred more than a day before the test. For this reason, the test is widely used in emergency care.

Lee Biosolutions is a leader in the biomaterials industry, providing the high quality products to clinical labs and researchers around the world, developing tomorrow’s cures. The company has provided the materials used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company’s newly redesigned website, www.leebio.com.